HUMAN MONOCLONAL ANTIBODIES AGAINST PROGRAMMED DEATH 1 (PD-1) PROTEIN AND CANCER TREATMENT METHOD USING ANTI-PD-1-ANTIBODIES SEPARATELY OR COMBINED WITH OTHER IMMUNOTHERAPEUTIC AGENTS Russian patent published in 2010 - IPC C12N15/09 

Abstract RU 2406760 C2

FIELD: chemistry; biochemistry.

SUBSTANCE: invention relates to biotechnology and is in form of isolated monoclonal antibodies, particularly human monoclonal antibodies which specifically bond with PD-1 with high efficiency. The invention also relates to molecules of nucleic acids which code the disclosed antibodies, expressed by vectors which contain such nucleic acids, as well as to host cells containing said vector. The invention also relates to methods of increasing immunoreaction, inhibiting cell growth, as well as treatment of infectious diseases in a person using the disclosed antibodies.

EFFECT: disclosed antibodies enable to carry out immunotherapy when treating human diseases and reducing their side effects.

10 cl, 100 dwg, 8 tbl, 25 ex

Similar patents RU2406760C2

Title Year Author Number
HUMAN MONOCLONAL ANTIBODIES AGAINST PROGRAMMED DEATH 1 (PD-1) PROTEIN AND CANCER TREATMENT METHOD USING ANTI-PD-1-ANTIBODIES SEPARATELY OR COMBINED WITH OTHER IMMUNOTHERAPEUTIC AGENTS 2013
  • Korman Alan Dzh.
  • Srinivasan Mokhan
  • Van Chanyuj
  • Selbi Mark Dzh.
  • Chen Bin
  • Kardarelli Zhozefin M.
RU2599417C2
HUMAN MONOCLONAL ANTIBODIES TO THE PROTEIN OF PROGRAMMED DEATH 1 (PD-1) AND METHODS OF TREATING CANCER USING ANTI-PD-1 ANTIBODIES ALONE OR IN COMBINATION WITH OTHER IMMUNOTHERAPEUTIC AGENTS 2016
  • Korman Alan Dzh.
  • Srinivasan Mokhan
  • Van Chanyuj
  • Selbi Mark Dzh.
  • Chen Bin
  • Kardarelli Zhozefin M.
RU2732924C2
HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR PROGRAMMED CELL DEATH 1 (PD1) PROTEIN AND METHODS OF TREATING CANCER WITH USING ANTI-PD1 ANTIBODIES EITHER INDIVIDUALLY, OR IN COMBINATION WITH OTHER IMMUNOTHERAPEUTIC AGENTS 2006
  • Korman Alan Dzh.
  • Srinivasan Mokhan
  • Van Chanjuj
  • Selbi Mark Dzh.
  • Chehn' Bin
  • Kardarelli Zhozefin M.
  • Khuan Khajchun'
RU2494107C2
ANTIBODIES DIRECTED TO PROTEIN OF PROGRAMMED DEATH OF CELL-1 (PD-1) 2014
  • King Devid Dzh.
  • Keri Merilin
RU2723050C2
ANTIBODIES AGAINST PD-1 AND THEIR USE 2018
  • Yang, Yi
  • Xie, Jingshu
  • Dong, Chunyan
  • Yang, Fang
  • Lu, Chengyuan
  • Cheng, Xiaodong
  • Shen, Yuelei
  • Ni, Jian
  • Guo, Yanan
  • Chen, Yunyun
RU2788616C2
PD-1 ANTIBODIES AND USE THEREOF 2016
  • Gu, Nana
  • Shao, Ke
RU2722451C1
NEW MONOCLONAL ANTIBODIES TO PROGRAMMED CELL DEATH 1 (PD-1) PROTEIN 2016
  • Zheng, Yong
  • Li, Jing
  • Gololobov, Gennady
  • Zhang, Xinhua
  • Yang, Baotian
  • Tang, Zhewei
  • Li, Dong
  • Xu, Jianqing
  • Wang, Zhuozhi
RU2757316C2
ANTIBODIES BINDING TO PD-1 AND THEIR APPLICATIONS 2019
  • Chen, Mintszyu
  • Tan, Vej
RU2773758C2
PD-1 BINDING ANTIBODIES AND METHODS OF THEIR USE 2019
  • Chen, Mintszyu
  • Tan, Vej
RU2812280C1
ANTI-PD-1 ANTIBODIES 2015
  • Zha Jiping
  • Sun Ziyong
  • Qiu Junzhuan
RU2711141C2

RU 2 406 760 C2

Authors

Korman Alan Dzh.

Srinivasan Mokhan

Van Chanjuj

Selbi Mark Dzh.

Chehn' Bin

Kardarelli Zhozefin M.

Dates

2010-12-20Published

2006-05-02Filed